FULC vs WST · $427.0M cap vs P/E 35, rev $1.72B
Fulcrum Therapeutics Inc (FULC) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported FULC revenue for 2025-09-30 was $0. Net income was -$54.5M. FULC currently screens at market cap $427.0M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
FULC currently screens at market cap $427.0M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the FULC and WST stock pages for the full models.
Not investment advice.